Milo Biotechnology Receives Investment from JumpStart, Rev1 Ventures

September 20, 2016

Milo Biotechnology, a Cleveland gene therapy developer aimed to help muscular dystrophy patients, received an undisclosed investment from JumpStart and Rev1 Ventures. The money will be used to prepare for multi-center clinical trials.

Read More  >